Xénia Gonda

Hungarian researcher

Born 1976-01-01 in ??? (nown/genid/4bb7ac88f4a9807f3b384a5b22d548de)

Xénia Gonda is …
instance of (P31):
humanQ5

External links are
P6178Dimensions author ID01255164703.19
P1960Google Scholar author IDgohAH3sAAAAJ
P2492MTMT author ID10003491
P1375NSK ID000640235
P496ORCID iD0000-0001-9015-4203
P3973PIM authority IDPIM2411724
P7293PLWABN ID9811571326805606
P3829Publons author ID1403370
P1053ResearcherIDB-2713-2008
P2038ResearchGate profile IDXenia_Gonda
P1153Scopus author ID8701430000
P214VIAF ID311814384

P166award received???Q64431597
P27country of citizenshipHungaryQ28
P69educated atSemmelweis UniversityQ277681
Eötvös Loránd UniversityQ390287
P734family nameGondaQ71736356
GondaQ71736356
GondaQ71736356
P735given nameXéniaQ25960438
XéniaQ25960438
P106occupationpsychiatristQ211346
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q2678122830 years against suicide: a summary of our research on depression and suicide prevention between 1985 and 2015
Q92423502A case-control study of paternal and maternal age as risk factors in mood disorders
Q38069919A new clinical evidence-based gene-environment interaction model of depression.
Q42374288A new stress sensor and risk factor for suicide: the T allele of the functional genetic variant in the GABRA6 gene
Q22242646A systematic review of the evidence on the treatment of rapid cycling bipolar disorder
Q34274031A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression
Q47328780Affective temperaments and hopelessness as predictors of health and social functioning in mood disorder patients: a prospective follow-up study
Q46510944Affective temperaments and self-harm in adolescents: a cross-sectional study from a community sample
Q37903095Affective temperaments in general population: a review and combined analysis from national studies
Q41418855Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
Q26801816An update on the conceptual and classification issues of anxiety, its neuroanatomy and problems of anxiolytic drug discovery
Q33930731Antidepressant treatment response is modulated by genetic and environmental factors and their interactions
Q34986537Antidepressant-resistant depression and antidepressant-associated suicidal behaviour: the role of underlying bipolarity
Q26801814Antidepressants, stressors and the serotonin 1A receptor
Q30834046Application of pharmacologic functional magnetic resonance imaging (phMRI) in the research of affective disorders
Q38446493Association of a trait-like bias towards the perception of negative subjective life events with risk of developing premenstrual symptoms
Q36098181Association of affective temperaments with blood pressure and arterial stiffness in hypertensive patients: a cross-sectional study
Q37978961Basic pharmacology of NMDA receptors
Q37725359Brain galanin system genes interact with life stresses in depression-related phenotypes
Q45983058Characterization of patients with mood disorders for their prevalent temperament and level of hopelessness.
Q34809427Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?
Q33720467Commentary: A Neural Basis for the Acquired Capacity for Suicide
Q38069924Cultural differences in the development and characteristics of depression.
Q47325756Cyclothymic temperament rather than polarity is associated with hopelessness and suicidality in hospitalized patients with mood disorders
Q47331425Cyclothymic-depressive-anxious temperament pattern is related to suicide risk in 346 patients with major mood disorders
Q41072936Decreased Openness to Experience Is Associated with Migraine-Type Headaches in Subjects with Lifetime Depression
Q42778940Diagnostic features, epidemiology, and pathophysiology of seasonal affective disorder
Q31155462Differential correlation of suicide and homicide rates according to geographical areas: A study with population-level data
Q38060483Early onset of action and sleep-improving effect are crucial in decreasing suicide risk: the role of quetiapine XR in the treatment of unipolar and bipolar depression
Q46427377Effects of depression, anxiety, self-esteem, and health behaviour on neonatal outcomes in a population-based Hungarian sample
Q38113575Epidemiology of suicide in bipolar disorders: a systematic review of the literature
Q42759698Etiopathology and therapy of seasonal affective disorder
Q33645300Extrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case report
Q37349901Financial difficulties but not other types of recent negative life events show strong interactions with 5-HTTLPR genotype in the development of depressive symptoms
Q48680489How does subjective experience of pain relate to psychopathology among psychiatric patients?
Q33892493How possible is the development of an operational psychometric method to assess the presence of the 5-HTTLPR s allele? Equivocal preliminary findings
Q35580138Humor appreciation of captionless cartoons in obsessive-compulsive disorder
Q37138875Hyperthymic affective temperament and hypertension are independent determinants of serum brain-derived neurotrophic factor level
Q36217733Identification of hypertensive patients with dominant affective temperaments might improve the psychopathological and cardiovascular risk stratification: a pilot, case-control study
Q35128573Impact of living with bipolar patients: Making sense of caregivers' burden
Q40726909Investigation of the association between arsenic levels in drinking water and suicide rate of Hungarian settlements between 2005 and 2011. A preliminary study
Q39305705Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Q39109653Measuring affective temperaments: a systematic review of validation studies of the Temperament Evaluation in Memphis Pisa and San Diego (TEMPS) instruments
Q90244390Modeling human temperament and character on the basis of combined theoretical approaches
Q38715620Mood Symptoms in Stabilized Patients with Schizophrenia: A Bipolar Type with Predominant Psychotic Features?
Q38453694Mood parameters and severe physical symptoms of the female reproductive cycle.
Q38561605NMDA receptor antagonists for depression: Critical considerations.
Q46655863Nitroglycerin-induced headaches
Q38069920Pharmaco- and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review.
Q38047710Pharmacological prevention of suicide in patients with major mood disorders
Q39103926Pharmacotherapy in bipolar disorders during hospitalization and at discharge predicts clinical and psychosocial functioning at follow-up
Q33573300Possible delayed effect of unemployment on suicidal rates: the case of Hungary
Q36076447Prediction and prevention of suicide in patients with unipolar depression and anxiety
Q38212363Predominant polarity as a course specifier for bipolar disorder: a systematic review
Q40948561Preliminary investigation of the possible association between arsenic levels in drinking water and suicide mortality
Q30697346Prevalence and psychosocial background of anxiety and depression emerging during the first trimester of pregnancy: data from a Hungarian population-based sample
Q44722133Prevalence of major depression in primary care practices in Hungary
Q38018903Prevention of depression-related suicides in primary care
Q43282199Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotype
Q26741695Psychological side effects of immune therapies: symptoms and pathomechanism
Q39775923Psychometric properties of the Gotland Scale for Depression in Italian psychiatric inpatients and its utility in the prediction of suicide risk
Q37233831Psychotherapeutic intervention and suicide risk reduction in bipolar disorder: a review of the evidence
Q38227312Rapid cycling in bipolar disorder: a systematic review
Q41931665Relationship between Temperament, Depression, Anxiety, and Hopelessness in Adolescents: A Structural Equation Model
Q30571488Relationship of suicide rates with climate and economic variables in Europe during 2000-2012.
Q38303164Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy
Q21203924Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study
Q43004800Seasonality and winter-type seasonal depression are associated with the rs731779 polymorphism of the serotonin-2A receptor gene
Q38865713Sensory processing patterns, coping strategies, and quality of life among patients with unipolar and bipolar disorders
Q98663844Sex differences in maturation and aging of human personality on the basis of a recently developed complex hierarchical model of temperament and character
Q52676367Significance of risk polymorphisms for depression depends on stress exposure.
Q41173366Social support decreases depressogenic effect of low-dose interferon alpha treatment in melanoma patients
Q90348380Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study
Q34677976Standardization of the NEO-PI-3 in the Greek general population
Q39225659Standardization of the TEMPS-A in the Greek general population
Q38219706Suicidal and violent behaviour in mood disorders: A major public health problem. A review for the clinician
Q38023982Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors
Q36535981Suicide behaviour of patients treated with antidepressants.
Q36972318Suicide in Hungary-epidemiological and clinical perspectives
Q37769731Suicide prevention programs through community intervention
Q40101161Temperaments in completed suicides: Are they different from those in suicide attempters and controls?
Q47332347Temperaments mediate suicide risk and psychopathology among patients with bipolar disorders
Q38688067The Role of Temperament in the Etiopathogenesis of Bipolar Spectrum Illness
Q91665877The UKB envirome of depression: from interactions to synergistic effects
Q41753444The association of affective temperaments with smoking initiation and maintenance in adult primary care patients
Q113288095The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.
Q34040400The effect of negative mood and major depressive episode on working memory and implicit learning
Q37954431The effect of pharmacotherapy on suicide rates in bipolar patients.
Q37260554The importance of depressive mixed states in suicidal behaviour.
Q37788434The possible contributory role of the S allele of 5-HTTLPR in the emergence of suicidality
Q38444717The possible protective role of personality dimensions against premenstrual syndrome
Q26781910The role of cognitive dysfunction in the symptoms and remission from depression
Q38069923The role of general practitioners in prevention of depression-related suicides.
Q36916692The role of hyperventilation: hypocapnia in the pathomechanism of panic disorder
Q37973144Treatment of mixed bipolar states
Q37665567Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis
Q35154505Variability in the effect of 5-HTTLPR on depression in a large European population: the role of age, symptom profile, type and intensity of life stressors
Q38404808Weak associations between the daily number of suicide cases and amount of daily sunlight
Q33812847White matter abnormalities: Insights into the pathophysiology of major affective disorders
Q36362157Why are migraineurs more depressed? A review of the factors contributing to the comorbidity of migraine and depression
Q30542123[Creativity and mental illness].
Q30564256[Sequence learning in major depressive disorder].